Sc on the cell-free conversion characteristics suggests that, besides the species barrier, polymorphism barriers play a significant role in the transmissibility of prion diseases.
Prion diseases such as Creutzfeldt-Jakob disease, GerstmannSträussler-Scheinker syndrome (GSS), bovine spongiform encephalopathy, and scrapie manifest as infectious, sporadic, and͞or inherited disorders (1) . They are characterized by the accumulation of an abnormal isoform (PrP Sc ) of the hostencoded cellular PrP(PrP c ) mainly in the central nervous system of mammals. This protease-resistant PrP Sc arises from protease-sensitive PrP C by a posttranslational process (2, 3) involving profound conformational changes of mainly ␣-helical (PrP C ) into ␤-sheeted (PrP Sc ) structure (4, 5) . The prion agent has been proposed to be composed largely, if not entirely, of these PrP Sc molecules (6, 7) .
Several PrP polymorphisms of humans have been associated with incidence, susceptibility, and pathology of the disease (1, 8) . For sheep, eight mutually exclusive PrP polymorphisms have been described (9) (10) (11) (12) (13) (14) (15) , resulting in nine different allelic variants. The allelic variants with polymorphisms at codons 112, 137, 141, 154, or 211 are rare and have not been significantly associated with any disease phenotype yet. In contrast, the PrP VQ allele (polymorphic amino acids at positions 136 and 171 are indicated by superscript single-letter code) is associated with high susceptibility to scrapie and short survival times of scrapie-affected sheep (9) (10) (11) (12) (15) (16) (17) (18) , whereas the PrP AR allele is associated with resistance or incubation times that span beyond the lifetime of sheep (9-12, 16, 17) . In breeds where PrP VQ is rare, e.g. the Suffolk breed, the wild-type PrP AQ allele is associated with susceptibility to scrapie, although with a low or incomplete penetrance (18, 19) . The mechanisms by which the different PrP allelic variants contribute to differences in scrapie susceptibility and survival time are not yet understood. However, it is possible that the various PrP C variants differ in their conversion kinetics into PrP Sc . Such differences may be due to differences in expression levels, in cotranslational or posttranslational modifications, and/or differences in conformational structures of the various PrP variants.
Recent in vitro studies have demonstrated that in a cell-free system hamster PrP C can be converted into protease-resistant forms that are at least similar, if not identical, to PrP Sc without the synthesis of new macromolecules (20) . Further biochemical studies with this cell-free system have shown that there is strain and species specificity in the PrP C -PrP Sc interaction that could account for the observed differences between prion strains and the barriers to interspecies transmission of prion agents, respectively (21, 22) . Species specificity in vitro was determined by specific amino acids between positions 113 and 188 of the hamster͞mouse PrP sequence (22) . Species specificity between human and mouse, as determined in vivo using transgenic mice carrying chimeric human͞mouse PrP genes, seems to be dependent on amino acid substitutions between positions 97 and 167 (23) . In a reciprocal manner using murine scrapieinfected neuroblastoma cells, the conversion of mouse PrP C into PrP Sc could be blocked by a single hamster-specific amino acid at position 138 of the murine PrP sequence (24) . In vivo studies with transgenic mice carrying chimeric human͞mouse PrP genes with single amino acid mismatches at position 109, 129, or 200 demonstrated that single amino acid substitutions in PrP can lead to an altered susceptibility to prions (25) . In addition, transmission of human Creutzfeldt-Jakob disease and fatal familial insomnia to human transgenic mice also indicated that polymorphisms in the PrP gene may lead to distinct PrP properties (26) . All these findings indicate that polymorphisms in the PrP gene might lead to differences in the PrP C -PrP Sc interaction and͞or conversion of PrP C into PrP Sc . In the present study, we explore whether sheep PrP C can be converted in vitro to protease-resistant forms using a cell-free system. In addition we investigated whether the various sheep PrP (ShPrP) allelic variants have different cell-free conversion characteristics and whether these characteristics reflect the observed differences in sheep scrapie susceptibility and the observed differences in survival times of scrapie-affected sheep in vivo.
MATERIALS AND METHODS
Cell Lines and PrP Constructs. The ShPrP allelic variants PrP VQ , PrP AQ , and PrP AR were cloned and analyzed as described previously (10) . PrP ORFs were subcloned between the ␤-globin intron and ␤-globin polyadenylylation sequences downstream the human cytomegalovirus (hCMV) promoter of expression vector pECV7, a derivative of expression vector pECV6 (27) in which the Rous sarcoma virus promoter has been substituted for the hCMV promoter. Mouse neuroblastoma cells (N2a cells; Hubrechts Laboratory, Utrecht, The Netherlands) were stably transfected with these constructs by electroporation (28) , hygromycine B (500 g͞ml)-resistant single-cell clones were isolated, and high PrP-expressing clones were selected by immunoperoxidase monolayer assay using the antipeptide antibody R521-7 (peptide corresponds to amino acids 94-105 of the ShPrP sequence) (29) . These cell lines were used for the isolation of the various ShPrP C variants.
Isolation of 35 S-PrP C . Cells expressing the different PrP variants were radiolabeled as initially described (30) (30, 31) using sarkosyl homogenization, ultracentrifugation, and PK digestion. After pelleting through a 20% sucrose cushion, the pellet was sonicated in 400 l of 0.1% sulfobetaine in Trisbuffered saline and stored in small portions at 4ЊC. Quantification (silver staining and Western blotting) of the PrP Sc revealed that the PrP Sc(VQ/VQ) and the PrP Sc(AQ/AQ) isolates contained about 135 g of PrP Sc per 24 g equivalent of brain. Both isolates were further diluted to a final concentration of 0.325 g͞ml and were briefly sonicated using a cuphorn sonicator before use.
Cell-Free Conversion Reaction. PrP Sc isolates in siliconized tubes were partially or more completely denatured for 2.5 h at 37ЊC in 2.5 M or 6 M guanidine⅐hydrochloride (Gdn⅐HCl), respectively. Aliquots of denatured PrP Sc (3.3 g) and 25 kcpm of purified 35 S-PrP C (Ϸ5-10 ng) were mixed and further diluted to a volume of 35 l at 1 M Gdn⅐HCl in conversion buffer (50 mM sodium citrate, pH 6.0͞5 mM cetylpyridinium chloride͞1% N-lauryl sarcosine͞protease inhibitors). Conversion reactions were performed for 2 or 5 days at 37ЊC, and the reaction mixtures were subsequently diluted to 100 l in 50 mM sodium citrate, pH 6.0, and digested with 35 g͞ml PK at 37ЊC for 1 h. Thereafter PK inhibitor (Pefabloc SC; Boehringer Mannheim) was added, and all proteins were precipitated with 4 vol of methanol at Ϫ20ЊC using 20 g of thyroglobulin as a carrier protein. Precipitated proteins were boiled and briefly sonicated in Laemmli sample buffer with 4 M urea, and 1͞10 vol was stored separately to be analyzed by Western blotting. All samples were separated by 15% SDS͞PAGE, the gels were fixed and subsequently enhanced using Amplify (Amersham), 35 S-labeled proteins were visualized on x-ray film, and integrated intensities of bands were measured using the Intelligent Quantifier (Bio-Image, Ann Arbor, MI). Comparable results were obtained between different sets of conversions, and only data of representative experiments are shown.
Western Blotting. Western blotting was performed by standard methods on nitrocellulose membranes, and proteaseresistant PrP was visualized using (1:1,000) R521-7 antibody and (1:1,000) alkaline phosphatase-goat anti-rabbit IgG (Zymed).
RESULTS

Expression of ShPrP
C in Cell Lines. Plasmid constructs encoding the wild-type ShPrP AQ , the ShPrP VQ , and the ShPr-P AR allelic variants were used to generate stably transfected N2a cells. Single-cell clones that showed intensive and equal staining with the R521-7 antibody in an immunoperoxidase monolayer assay were selected for further use. These PrP Cexpressing clones contained about 4-6 random integrated copies of the expression vector (data not shown), and almost equal amounts of the various radiolabeled PrP C variants could be isolated. The various PrP C variants were labeled with pressed in N2a cells did not show notable differences in posttranslational modifications, and all three PrP C variants could be reduced to a single band of 27 kDa by inhibiting glycosylation with tunicamycin D (compare Fig. 2, lanes 1-3 with Fig. 3a, lanes 1-3) .
Conversion of Sheep PrP C to Protease-Resistant Forms. To define the most optimal partial renaturation conditions of the ShPrP Sc for successful conversions, we first pretreated ShPrP Sc under various Gdn⅐HCl conditions. By measuring PK-resistant PrP Sc on Western blots we found Ͼ95% denaturation and Ͼ95% renaturation of at least the R521 epitope (amino acid residues 94-105) if denatured in 2.5 M Gdn⅐HCl for 2-24 hr at 37ЊC and subsequently renatured for 5 days in 0.75-1.0 M Gdn⅐HCl at 37ЊC.
To explore whether ShPrP C could be converted to proteaseresistant forms in a cell-free system, as shown for hamster and mouse PrP C by Kocisko et al. (20, 22) , 35 S-ShPrP CVQ was incubated at 37ЊC for 5 days (1 M Gdn⅐HCl) with partially denatured (Ͼ2.5 h in 2.5 M Gdn⅐HCl at 37ЊC) ShPrP Sc(VQ/VQ) and 35 S-ShPrP CAQ was incubated under the same conditions with partially denatured ShPrP Sc(AQ/AQ) . After PK digestion, PK-resistant 35 S-ShPrP bands were detectable in both conversion reactions (Fig. 2, lanes 4 and 8) . ShPrP Sc more completely denatured with 6 M Gdn⅐HCl induced very little conversion to PK-resistant forms in similar reactions (Fig. 2, lanes 10 and 11) . 4) and multiplication by 10 (starting material ϭ 10%). To give an indication of conversion efficiencies in conversions with glycosylated PrP C , the bands between 27-39 kDa (Fig. 2, lanes 1-3) and between 21-33 kDa (Fig. 2, lanes 10-15) Although the gels revealed a smear rather than discrete bands, predominant 35 S-labeled PK-resistant bands with molecular masses of 32-33 kDa, 26-27 kDa, and 20-21 kDa were detectable, indicating a downward shift in molecular mass by PK digestion of about 6 kDa as expected for bonafide PrP-res products (compare Fig. 1, lanes 4 and 5) .
Polymorphisms Modulate the Cell-Free Conversion of PrP C to Protease-Resistant Forms. Although the amounts of conversion products are not easy to quantify from a smear of 35 S-labeled PK-resistant PrP, it is obvious from Fig. 2 (Fig. 2, lanes 4-6) . In the PrP Sc(AQ/AQ) -induced reactions, the three PrP C allelic variants also converted with different efficiencies into PrP-res (Fig. 2, lanes 7-9) .
To be able to quantify the conversion products more accurately and to address if N-linked glycosylation plays a role in determining the differences in conversion efficiency between the three PrP C variants, we repeated the above experiments with unglycosylated PrP C variants that were radiolabeled in the presence of tunicamycin D to obtain more discrete and quantifiable PrP bands (Fig. 3a, lanes 1-3) . From the hamster cell-free conversions it was already known that the unglycosylated form of hamster PrP C converted more efficiently into protease resistant forms than the glycosylated form of hamster PrP C (20, 22) . Mock transfected cell lines did not show discrete labeled material indicating the absence of endogenous mouse PrP C in the preparations (Fig. 3a, lane 4) . The radiolabeled PrP C products did not convert into protease-resistant products when incubated for 5 days under conversion conditions without PrP Sc (Fig. 3a, lanes 5-8) . However, incubation of nonglycosylated PrP CVQ , PrP CAQ , or PrP CAR under conversion conditions for 2 or 5 days with either PrP Sc(VQ/VQ) or PrP SC(AQ/AQ) resulted in discrete and readily quantifiable protease-resistant bands of predominantly 20-21 kDa (Fig. 3a, lanes 9-11, 13-15 , 17-19, and 21-23). As expected, the material from the mock transfected cells did not produce such PK-resistant bands (Fig.  3a, lanes 12, 16, 20, and 24) . The downward shift in molecular mass by PK digestion was about 6 kDa, which is equal to the downward shift found for the converted glycosylated PrP C variants (Fig. 2) and PrP Sc isolated from sheep brain (Fig. 1,  lanes 4 and 5) . The bar diagram (Fig. 3b) shows the percentages of PrP C that are converted into PrP-res by quantification of the 20-21-kDa PK-resistant conversion products and comparison with the 27-kDa input PrP C . For quantification of the conversions with glycosylated PrP C the region between 21 and 33 kDa of the conversion products (Fig. 2) was used (only to give a relative indication of these conversion efficiencies). PrP VQ , which is associated with high susceptibility to scrapie and short survival times in scrapie-affected sheep, is overall the allelic form of PrP C that is most efficiently converted to PrP-res (Fig. 3b, bars 1, 2, 10, and 11) . The homologous conversions with this allelic form (Fig. 3b, bars 1 and 2 ) seem more efficient than the heterologous conversions (Fig. 3b, bars 10 and 11) . PrP AQ , which is associated with intermediate susceptibility to scrapie (with an incomplete penetrance) and with intermediate survival times in scrapie-affected sheep, is less efficiently converted to PrP-res (Fig. 3b, bars 7, 8, 16 , and 17). PrP AR , which is associated with resistance to scrapie and with incubation times that span beyond the lifetime of sheep, is poorly converted to PrP-res (Fig. 3b, bars 4, 5, 13, and 14) .
The conversion data obtained with the different allelic forms of PrP Sc revealed that not only the polymorphisms in PrP C determine the conversion efficiencies. Differences in conversion efficiencies were also obtained using PrP Sc isolates from sheep with different PrP genotypes (Fig. 3b, bars 1-9 and   10-18) . The PrP Sc(VQ/VQ) induced conversion with homologous PrP CVQ was the most efficient reaction in which about 35% of the initial PrP C was converted into 20-21 kDa PrP-res (Fig. 3b,  bars 1 and 2) . The PrP Sc(VQ/VQ) -induced conversion with heterologous PrP CAQ resulted in an intermediate (17-24%) conversion into PrP-res (Fig. 3b, bars 7 and 8) . In contrast, the PrP Sc(AQ/AQ) -induced conversions with either heterologous PrP CVQ or homologous PrP CAQ resulted in almost equal intermediate conversion efficiencies (Fig. 3b, bars 10, 11, 16 , and 17). PrP CAR was poorly converted into PrP-res by both PrP Sc isolates (Fig. 3b, bars 4, 5, 11, and 14) .
The intriguing efficiency differences between the conversions of nonglycosylated PrP CVQ , PrP CAQ , and PrP CAR were consistent with the relative efficiency differences observed with (the inaccurate quantifiable) glycosylated forms of PrP C (compare Fig. 3b, bars 2, 5, 8, 11 , 14, and 17 with bars 3, 6, 9, 12, 15, and 18). Therefore glycosylation of PrP C seems to be of minor or no importance in determining the differences in conversion efficiencies between the various PrP C variants.
To conclude that the differences in amounts of conversion products are only the result of the polymorphisms present in PrP, it is important to have as close to identical concentrations of PrP Sc and PrP C in each reaction. All conversions with the same PrP C variant have identical PrP C concentrations on the basis of protein content, because we aliquoted equal volumes from one batch into the different conversion reactions. All conversions with different PrP C variants have equal amounts of PrP C on the basis of radiolabel and equal immunoperoxidase monolayer staining of the PrP C -expressing cells. The content of PrP Sc in each conversion reaction and the rate of unfolding͞refolding was compared by Western blotting 1͞10 vol of each conversion reaction (Fig. 3c) . This blot shows that the PrP Sc isolates contained about the same quantity of protease-resistant PrP (Fig. 3c, lanes 1 and 9) . At least the R521 epitope of PrP Sc became PK-sensitive after pretreatment in 2.5 M Gdn⅐HCl (Fig. 3c, lanes 2 and 10) and recovered PK resistance after 2 days of renaturation (Fig. 3c, lanes 3-6 and  11-13) . Renaturation in the presence of different allelic forms of PrP C did not detectably inhibit the refolding of PrP-res (Fig.  3c, lanes 3-5 and 11-13 ). The denaturation of PrP Sc with 6 M Gdn⅐HCl was not reversible (Fig. 3c, lane 7 and 8) . We concluded that, because the amounts of PrP Sc and PrP C of the different allelic forms were similar in each conversion, differences in quantity of conversion products were probably solely an effect of the primary ShPrP amino acid sequence.
DISCUSSION
In this paper we report, for the first time to our knowledge, the cell-free conversion of sheep PrP C into protease-resistant forms similar or identical to ShPrP Sc . In addition we report that polymorphisms that are associated with differences in scrapie susceptibility and differences in survival times of scrapie affected sheep also account for comparable differences in cell-free conversion efficiencies. This suggests that the PrP conversion kinetics are directly related to scrapie susceptibility and the length of survival times of sheep affected by natural scrapie. Because there is a good correlation between in vitro cell-free conversion data and in vivo scrapie susceptibility data thus far (9-12, 16, 17) , this assay may be useful for determining the relative susceptibility of individual allelic forms of PrP to different prion sources and͞or the relative transmissibility of these prion sources.
The efficiency of the cell-free conversion reaction was strongly dependent on both the type of PrP C variant and on the source of PrP Sc used to induce the conversion. The PrP CVQ variant, which is associated with high susceptibility and short survival times of scrapie-affected sheep, was very efficiently converted into protease-resistant forms. The wild-type PrP CAQ variant, which is associated with a neutral effect on suscepti-bility and intermediate survival times, was converted into protease-resistant forms with intermediate efficiency. The PrP CAR variant, which is associated with resistance and long survival times, was poorly converted into protease-resistant forms. Although in some breeds, i.e. Suffolk and Romanov, PrP AQ is associated with an incomplete penetrance to scrapie susceptibility, probably due to the low incidence of PrP VQ (16, 19, 32) , PrP VQ carriers of these breeds still have the shortest scrapie survival time (16, 32) . Another point of interest is the finding that PrP CAR can be converted, although with a very low efficiency, into protease-resistant forms suggesting the possibility of scrapie agent replication in PrP AR -carrying sheep as has been described by Ikeda et al. (32) .
Not only the primary PrP C sequence was found to determine the conversion characteristics but also the primary amino acid sequence of PrP Sc (12, 17) . It is also consistent with the striking behavior of the CH1641 scrapie isolate, which was primarily isolated from a positive line (mainly PrP VQ -carrying) NPU-Cheviot sheep, when passaged in positive-line or negative-line (non-PrP VQ ) Cheviot sheep. The first (primary) intracerebral passage of this positive-line material to positiveline Cheviot sheep resulted in short incubation times. Passage of the primary CH1641 isolate into negative-line Cheviot sheep resulted in longer incubation times (33) probably due to polymorphism barriers. If the negative-line passaged isolates were subsequently passaged in negative-line Cheviot sheep the incubation times in this line of sheep decreased (17, 33) . A subsequent passage from these negative-line to positive-line Cheviot sheep increased the incubation times dramatically (17, 33) again probably due to the polymorphism barrier.
Modification of scrapie isolate properties were also found in mice scrapie transmission experiments in which the properties of PrP Sc could be modified by passage of scrapie isolates through mice with different PrP C amino acid sequences (34) . Further support is derived by the transmission of human Creutzfeldt-Jakob disease or GSS to mice expressing chimeric mouse͞human PrP transgenes carrying specific mutations. Mice carrying the Glu-to-Lys mutation at position 200 (E200K) were resistant to human prions from a patient with GSS carrying a Pro-to-Leu mutation at position 102 (P102L) but were susceptible to prions from familial Creutzfeldt-Jakob disease patients harboring the E200K mutation. However, mice carrying the mouse͞human transgene with the P102L mutation were susceptible to GSS prions (24) .
Interestingly, a homogenate of bovine spongiform encephalopathy, of which the primary amino acid sequence (at the polymorphic amino acid positions of sheep PrP) is best comparable with the sheep PrP AQ genotype, gives the shortest incubation times in PrP AQ sheep if inoculated by the intracerebral route. If inoculated via the longer oral route however, PrP VQ sheep have the shortest incubation time (17) . Probably inoculation via the oral route, compared with inoculation by the intracerebral route, extends the incubation time long enough to overcome the polymorphism barrier and subsequently allows the agent to spread more quickly using PrP CVQ instead of PrP CAQ . Preliminary data from cell-free conversion experiments with the three PrP C variants using PrP Sc isolated from a PrP VQ/AQ sheep suggest that this PrP Sc isolate mainly consists of PrP CVQ because this PrP Sc(VQ/AQ) isolate converted PrP CVQ at least three times as efficiently as PrP CAQ into protease-resistant forms (Fig. 4) . This again is consistent with the finding that PrP CVQ is more readily converted into PrP-res than PrP CAQ . Thus in sheep containing the mutant PrP VQ allele, it is likely that the PrP CVQ variant will be the preferred converted variant, similar to what has been found for the mutant human PrP allele in GSS (35) . Consequently, after infection of flocks of sheep having the PrP VQ allele, the agent pool would be predicted to become enriched for PrP VQ .
This study shows that the cell-free system is an excellent system to measure the relative transmissibility of a prion source to animals or humans with known PrP genotypes. Although the mechanism by which PrP C is converted into PrP Sc and the mechanism by which polymorphisms in PrP modulate the conversion efficiency is not yet clear, studies with the cell-free conversion reaction (36) and small synthetic PrP peptides (37) are consistent with a nucleated polymerization mechanism (38, 39) . The conversion of PrP C to PrP Sc involves a transition from a state that is predominantly ␣-helical to one that is largely ␤-sheet (4, 5, 40) . PrP C may rapidly interchange between these two conformations in its normal monomeric state but only be stabilized and accumulated in the ␤-sheet conformation by binding to a preformed PrP Sc polymer (37, 38, 41) . Alternatively, the transition to the PrP Sc conformation may only be induced (catalyzed) upon direct binding of PrP C to the PrP Sc polymer. PrP polymorphisms may influence the equilibrium between the ␣-helical and ␤-sheet conformations in PrP C and/or the ease with which PrP Sc induces PrP C to switch to the ␤-sheet conformation. Polymorphisms that destabilize the ␣-helical conformation of PrP C would be expected to have these effects.
In this study we have tested the cell-free conversion of three (PrP VQ , PrP AQ , and PrP AR ) of the nine PrP variants found in sheep, including the two allelic variants that are associated with the extremes in susceptibility to scrapie (highly susceptible or resistant). From the other six allelic variants: PrP T112AQ , PrP AT137Q , PrP AF141Q , PrP AH154Q , PrP AH , and PrP AQQ211 , it is not known whether they are significantly associated with susceptibility to natural or experimental scrapie in sheep. Using the recently published high-resolution NMR structure of the mouse PrP C domain containing residues 121-232 together with Novotny secondary structure predictions, it might be possible to rationalize the effects of certain of the sheep PrP polymorphisms on PrP C conformation. At least two other polymorphisms in the sheep PrP gene could be associated, by these predictions, with scrapie susceptibility. The PrP AT137Q variant FIG. 4 . Cell-free conversion of nonglycosylated 35 S-PrP C into protease-resistant forms. PrP Sc from a heterozygous sheep was pretreated in 2.5 M Gdn⅐HCl. Reactions were incubated for 2 or 5 days at 37ЊC (1 M Gdn⅐HCl) and subsequently PK-digested (except lane 1). Lane 1 contains approximately 2-5% of the input material (Std) for conversions shown in lanes 2-7. Samples were analyzed by 15% SDS͞PAGE. Molecular mass markers (kDa) are indicated at the left.
could be grouped with the PrP VQ variant, because both give a prediction of more ␤-sheeted structure and a change in hydrophobicity in the loop between ␤-sheet-1 and ␣-helix-1, which may indicate helix breaking or hydrophobic core destabilizing properties as found in theoretical studies of the Ala to Val mutation at position 117 in the human PrP sequence (42) . The PrP AH154Q variant is protective against scrapie, and no scrapie-affected sheep with this genotype have been found (10, 12, 15, 32) . This variant could be grouped with the PrP AR variant, because both involve a charge inversion compared with the wild-type PrP AQ variant. The latter two polymorphisms are located in the loops between ␣-helix-1 and ␤-sheet-2, and between ␤-sheet-1 and ␣-helix-3, respectively, and may influence the stabilization of the hydrophobic core or the dipolar character of PrP C . The other four alleles did not show differences in Novotny secondary structure predictions other than the PrP AQ variant and therefore probably may be grouped with this variant. Additional cell-free conversion data with all known sheep PrP C variants may enable us in the near future to determine more exactly the relative scrapie susceptibility between sheep having different PrP alleles.
